News from shire plc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 25, 2015, 07:00 ET

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity

The company enters into new agreement with Sanquin  Shire plc (LSE: SHP, NASDAQ: SHPG) announced today it has entered into an agreement with...

Aug 04, 2015, 07:30 ET

Shire Proposes Combination With Baxalta to Create the Leading Global Biotech Company Focused on Rare Diseases

Strong strategic fit and industry-leading portfolio of combined company is projected to deliver immediate value creation and generate $20 billion...

Aug 03, 2015, 07:00 ET

Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset

Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that it has acquired New York-based, privately held Foresight Biotherapeutics Inc. for $300...

Jul 23, 2015, 07:01 ET

Shire Announces Second Quarter Earnings and Increases Full Year Non GAAP Diluted EPS Guidance to Mid-to-High Single Digit Growth

Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the three months to June 30, 2015. Non GAAP Financial Highlights...

Jul 22, 2015, 07:00 ET

Vyvanse® (lisdexamfetamine dimesylate) Positive Top-Line Results in Maintenance of Efficacy Study in Adults with Moderate to Severe Binge Eating Disorder

For U.S. Audiences Only - Shire plc (LSE: SHP, NASDAQ: SHPG) today reported positive top-line results from a 39-week, long-term maintenance of...

Jul 01, 2015, 11:14 ET

Shire startet Filmwettbewerb "Gaucher im Rampenlicht" und ruft zu Einsendungen von Videos auf, die das Leben mit Morbus Gaucher beschreiben

  - Der Wettbewerb soll von Morbus Gaucher betroffene Menschen zusammenbringen und das Bewusstsein für diese seltene Krankheit...

Jul 01, 2015, 07:00 ET

Shire Launches Spotlight on Gaucher Film Contest and Calls for Video Entries Sharing Experiences of Living with Gaucher Disease

  - The contest aims to unite people impacted by Gaucher disease and raise awareness of this rare condition - Gaucher disease is...

Jun 15, 2015, 07:00 ET

Shire Names Bill Mordan General Counsel and Corporate Secretary; Appoints Michele Galen Head of Communications and Public Affairs

Shire plc (LSE: SHP, NASDAQ: SHPG) announces the appointment of Bill Mordan as General Counsel and Corporate Secretary, reporting to CEO Flemming...

Jun 11, 2015, 02:00 ET

Shire Appoints Olivier Bohuon to its Board of Directors

Shire plc (LSE: SHP, NASDAQ: SHPG) announces the appointment of Olivier Bohuon to the Shire Board of Directors as a Non-Executive Director....

Jun 01, 2015, 07:00 ET

Shire to Participate at the Jefferies 2015 Global Healthcare Conference

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it will be participating in the Jefferies 2015 Global Healthcare Conference in New York, NY on...

May 26, 2015, 02:00 ET

New Shire Research to be Presented at World Congress on ADHD Highlights Treatment Portfolio, Pipeline and Caregiver Experiences

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that new data advancing the understanding of attention deficit/hyperactivity disorder (ADHD)...

May 26, 2015, 02:00 ET

Shire présentera les conclusions de ses nouvelles recherches sur les traitements, les produits en cours de développement et les expériences des soignants au Congrès mondial sur le TDAH

Shire plc (LSE: SHP, NASDAQ: SHPG) annonce ce jour qu'elle présentera de nouvelles données facilitant une meilleure compréhension...

May 26, 2015, 02:00 ET
May 11, 2015, 08:00 ET

Shire to Present New Research at American Psychiatric Association Annual Meeting

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that new research highlighting its commitment to the treatment and management of psychiatric...

May 06, 2015, 10:26 ET

Shire to Participate at the Deutsche Bank 40th Annual Healthcare Conference

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it will be participating in the Deutsche Bank 40th Annual Healthcare Conference in Boston, MA on...

May 04, 2015, 07:00 ET

Shire and Foundation Fighting Blindness Announce New Research Agreement

Shire plc (LSE: SHP, NASDAQ: SHPG) and the Foundation Fighting Blindness today announced a new agreement focused on furthering research for a...

Apr 30, 2015, 07:01 ET

Jeff Poulton Appointed Shire Chief Financial Officer and Joins Board of Directors

Shire plc (LSE: SHP, NASDAQ: SHPG) announces the appointment of Jeff Poulton as Chief Financial Officer (CFO) and member of the Executive...

Apr 30, 2015, 07:00 ET

Shire Delivers Strong Revenue Growth and Cash Generation; 20% Increase in Non GAAP Earnings per ADS

- Continued Advancement Toward Goal of Becoming a Leading Global Biotechnology Company Shire (LSE: SHP, NASDAQ: SHPG) announces unaudited...

Apr 09, 2015, 13:55 ET

U.S. FDA Grants Priority Review to Lifitegrast NDA for the Treatment of Dry Eye Disease in Adults

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the United States Food and Drug Administration (FDA) has accepted for filing the New Drug...

Apr 09, 2015, 02:00 ET

Shire Reports Topline Results from First of Three Placebo-Controlled Phase 2 Studies of SHP625 (LUM001) in Children with Alagille Syndrome

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the 13-week Phase 2 IMAGO trial of its investigational compound SHP625 (LUM001) did not...